(Q33285568)

25 July 2017

title

An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine (English)

1 reference

25 July 2017

1 reference

7

Seth Owusu-Agyei

2 references

25 July 2017

ORCID Public Data File 2021

Daniel Chandramohan

1

object named as

Daniel Chandramohan

1 reference

25 July 2017

2

Abraham Hodgson

1 reference

25 July 2017

5

Kwaku Asante

1 reference

25 July 2017

Paul Coleman

3

1 reference

25 July 2017

Rita Baiden

4

1 reference

25 July 2017

Elizabeth Awine

6

1 reference

25 July 2017

Dominique Boutriau

8

1 reference

25 July 2017

Christopher B Nelson

9

1 reference

25 July 2017

Brain Greenwood

10

1 reference

25 July 2017

language of work or name

English

0 references

publication date

7 May 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

25 Suppl 1

1 reference

25 July 2017

page(s)

A83-91

1 reference

Manson Lecture. Meningococcal meningitis in Africa

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Emergence of meningococcal meningitis caused by W 135 subgroup in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Control of meningococcal infection in the African meningitis belt by selective vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Control of epidemic meningococcal meningitis by mass vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Tetravalent (A, C, Y, W 135) meningococcal vaccine in children: immunogenicity and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.047

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.04.047

1 reference

release_qunyi44junddxiqrzzcnn3bmz4

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qunyi44junddxiqrzzcnn3bmz4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference